UNSPSC 51271616: Pyrrocaine

This classification denotes an anesthetic agent with the molecular formula C14H20N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9D47L94CPW, chemically known as 1-pyrrolidineaceto-2,6-xylidide but generally known as pyrrocaine, which bears US NIH Compound Identifier 24361. European Medicines Agency schedules Pyrrocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10180MIG.

UNSPSC 51271616 Pyrrocaine is a Commodity code that covers local anesthetic pharmaceutical products supplied to state and local government healthcare facilities through cooperative purchasing frameworks. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota, Oregon, and other MMCAP member jurisdictions. The solicitation requires manufacturers to supply products with specific National Drug Codes (NDCs), detailed product information including strength, dosage form, trade names, and packaging configurations, and to maintain compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). Vendors must hold contractual relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and carry comprehensive insurance including $5,000,000 commercial general liability and $2,000,000 network security and privacy liability. The cooperative purchasing vehicle is the dominant issuing mechanism for this commodity code within state and local procurement.

MMCAP's RFP for generic pharmaceuticals closed March 26, 2026, with evaluation weighted primarily on price competitiveness (75 percent) and secondarily on fixed pricing, administrative compliance, EDI capability, and agreement to a 3 percent administrative fee (5 percent each). Awarded vendors become effective July 1, 2026, with a two-year initial contract term and optional extensions. The solicitation covers a multi-state footprint through the MMCAP cooperative, which pools purchasing power across state agencies and local government healthcare operations. No specific set-aside designations were identified in the RFP documentation. Performance penalties range from $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials, and all products must have expiration dates at least one year from manufacture with a minimum six-month shelf life.